BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2480029)

  • 21. [Hypervolemic hemodilution with bloodletting in patients with peripheral arterial occlusive disease].
    Kiesewetter H; Blume HJ; Jung F; Bach R; Spitzer S; Leipnitz G; Schieffer H; Bette L; Wenzel E
    Vasa Suppl; 1988; 26():107-12. PubMed ID: 2462283
    [No Abstract]   [Full Text] [Related]  

  • 22. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
    Haller M; Brechtelsbauer H; Akbulut C; Fett W; Briegel J; Finsterer U
    Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)].
    Jung F; Waldhausen P; Spitzer S; Wenzel E
    Acta Med Austriaca; 1991; 18 Suppl 1():9-15. PubMed ID: 1719736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
    Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
    Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
    Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
    Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal hematocrit in patients with intermittent claudication. Exercise-induced muscle tissue oxygen pressure after stepwise hemodilution.
    Höffkes HG; Saeger-Lorenz K; Ehrly AM
    Acta Med Austriaca; 1991; 18 Suppl 1():16-9. PubMed ID: 1950385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemodilution in peripheral arterial occlusive disease].
    Becsi C; Wehofer D; Weidinger P
    Vasa Suppl; 1988; 26():113-5. PubMed ID: 2462284
    [No Abstract]   [Full Text] [Related]  

  • 28. [Preoperative hypervolemic hemodilution with 6% hydroxyethyl starch 130/0,4 (HES 130/ 0.4) solution as a way of reducing needs for donor blood transfusion].
    Winter V; Gille J; Richter A; Sablotzki A; Wiedemann B
    Anesteziol Reanimatol; 2006; (2):43-7. PubMed ID: 16758944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
    Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
    Dtsch Med Wochenschr; 1987 May; 112(22):873-8. PubMed ID: 3556133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of hydroxyethyl-starch on hemorheology in patients with chronic liver disease].
    Lao JX; Gu MN; Xiao JF; Lu XM
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Apr; 25(4):438-40. PubMed ID: 15837650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
    Kröll W; Pölz W; Colombo T; Steindorfer P
    Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypertonic-hyperoncotic volume replacement (7.5% NaCl/10% hydroxyethyl starch 200.000/0.5) in patients with coronary artery stenoses].
    Prien T; Thülig B; Wüsten R; Schoofs J; Weyand M; Lawin P
    Zentralbl Chir; 1993; 118(5):257-63; discussion 264-6. PubMed ID: 7686707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Autotransfusion with leap-frog technique in patients with coronary heart disease and planned aortocoronary venous bypass].
    Kiesewetter H; Jung F; Pindur G; Koscielny J; Jakobs K; Wenzel E
    Infusionsther Transfusionsmed; 1994 Apr; 21(2):96-103. PubMed ID: 7517239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experiences with the clinical use of iso- and hypervolemic hemodilution in conservative therapy of vascular diseases].
    Turowski A; Schmidt H; Sternitzky R; Brehme S; Keysser G; Hiebsch G; Hiebsch U
    Vasa Suppl; 1991; 32():338-41. PubMed ID: 1771528
    [No Abstract]   [Full Text] [Related]  

  • 35. [Accumulation of two different hydroxyethyl starch preparations in the placenta after hemodilution in patients with fetal intrauterine growth retardation or pregnancy hypertension].
    Heilmann L; Lorch E; Hojnacki B; Müntefering H; Förster H
    Infusionstherapie; 1991 Oct; 18(5):236-43. PubMed ID: 1722779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemodilution in acute arterial circulatory disorders of the retina].
    Arend O; Hoberg A; Bertram B; Reim M; Wolf S
    Acta Med Austriaca; 1991; 18 Suppl 1():66-8. PubMed ID: 1719735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.
    Ekelund A; Reinstrup P; Ryding E; Andersson AM; Molund T; Kristiansson KA; Romner B; Brandt L; Säveland H
    Acta Neurochir (Wien); 2002 Jul; 144(7):703-12; discussion 712-3. PubMed ID: 12181704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseases.
    Treib J; Haass A; Pindur G; Grauer MT; Treib W; Wenzel E; Schimrigk K
    Arzneimittelforschung; 1996 Nov; 46(11):1064-6. PubMed ID: 8955865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treadmill ergometer multistage test: a new alternative in diagnosis and therapeutic control of peripheral arterial occlusive disease].
    Weidinger P; Bachl N; Liebenberger S
    Vasa Suppl; 1988; 26():48-50. PubMed ID: 2462285
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hemorheologic and clinical in vitro and in vivo studies of the effectiveness of isovolemic hemodilution using Gelafusal and Infukoll M40 in patients with peripheral arterial occlusive disease].
    Pöhlmann G; Braumann A; Grohmann G
    Vasa Suppl; 1991; 32():342-4. PubMed ID: 1722914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.